InsidersTradesSigma
Follow the 艾德生物 share price and the full management transaction log of the company, a listed equity based in China. Shares trade on the CN market, under the supervision of SSE / SZSE (CSRC). Operating in the Health Care sector, 艾德生物 has published 3 reports. Market capitalisation: €6.7bn. The latest transaction was disclosed on 8 August 2023 (Purchase). Among the most active insiders: 杜立威. All data is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
艾德生物 es una empresa especializada en el sector de la salud y farmacéutico, centrada en el desarrollo de soluciones biofarmacéuticas. Cotiza en el mercado XSHE.